FDA Person
Office of the CommissionerSam Haidar
View detailed information about Sam Haidar, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner. Took part in 1 inspection of 1 company, 2025.
Inspections (1)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| May 23, 2025 | Sigan Industries Group Inc. | Not classified | Drug Quality Assurance | #1264005 |
Documents (10)
- 483 · Cetero Research · December 10, 2010
- WARNING LETTER · SNBL USA LTD. · November 20, 2009
- EIR · GVK Biosciences Pvt. Ltd. · October 9, 2014
- 483 · Clinogent (A Division of GVK Biosciences Pvt. Ltd.) · October 9, 2014
- EIR · Covance Laboratories Inc. · June 6, 2014
- 483 · GVK Biosciences Pvt. Ltd.
- 483 · GVK Biosciences Pvt. Ltd. · October 9, 2014
- 483 · Sigan Industries Group Inc. · May 23, 2025
- 483 · GFA Production Xiamen Co., Ltd. · December 8, 2023
- 483 · Asphar Research Labs Private Limited · July 17, 2024
Frequently inspected with (1)
Related Office
Person Information
Name
Sam Haidar
Title
Senior Advisor, Office of Study Integrity and Surveillance
Role
Regulatory Personnel
ID: 658889fd-f946-4811-b3f5-7651cc6ce660
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.